Fact CheckerSign in

NCT07546357Not yet recruiting

AIManage Using an AI-driven CDS and Chatbot

AIManage: Using an AI-driven CDS and Chatbot for the Management of Patients on Incretin Mimetic Medications

Source: ClinicalTrials.gov · Last updated 22 Apr 2026

Brief summary (registry, in English)

The objective of this project is to define and test the GenAI-powered Clinical Decision Support (CDS) tool, AIManage, providing a broad range of incretin mimetic medication management services to optimize dose titrations. The study will take place across primary care and obesity medicine clinics at NYUH. The study is currently conducting formative data collection for tool refinement (Phase 1). Once completed, a cluster randomized controlled trial of the AIManage tool will be undertaken (Phase 2).

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
16 (estimated)
First submitted
10 Apr 2026
Start date
1 Jun 2026
Primary completion date
30 Mar 2028
Lead sponsor
NYU Langone Health
Diseases
Obesity
NCT number
NCT07546357

What you commit to

  • Study type: Interventional
  • Planned participants: 16
  • From 1 Jun 2026 to the primary completion date, 30 Mar 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Provider Exclusion Criteria (Phase 1) • Refuse to participate
  • Patient Exclusion Criteria (Phase 1)
  • Refuse or are unable to provide informed consent;

Who the study is looking for

  • Provider Eligibility Criteria (Phase 1)
  • Primary or bariatric care provider (MD/DO, NP) practicing at the participating NYULH clinics,
  • Provide care to at least 5 patients prescribed an IMM.
    • Patient Eligibility Criteria (Phase 1)
  • (Phase 1) Currently taking an IMM or have taken an IMM in the past 6 months;
  • Fluency in English or Spanish;
  • Be willing to send/receive text messages; and
  • Be \> 18 years of age.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
NYU Langone Health
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.